Recent News

• 12.01.2025 - Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly
• 09.22.2025 - Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration
• 09.05.2025 - Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 12.01.2025 - SC 14D9/A Solicitation, recommendation statements
• 11.28.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.21.2025 - 8-K Current report
• 11.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.10.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 11.07.2025 - SC 14D9 Solicitation, recommendation statements
• 11.07.2025 - SC TO-T Tender offer statement by Third Party
• 10.24.2025 - EX-99.1 EX-99.1
• 10.24.2025 - SC TO-C Written communication relating to an issuer or third party
• 10.24.2025 - 8-K Current report